Future therapeutic strategy for controlling NRF2-addicted cancers based on their metabolic features The dependency on glutamine and glutamate is regarded as an Achilles heel of NRF2-addicted cancer cells
Retatrutide is an investigational triple receptor agonist that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Therefore, more studies in humans are needed to support the findings in animals, with a unique methodology, specifying the exact proteins/isoenzymes analyzed, with an adequate number of participants involved, a clear distinction of infertile and fertile men from infertile couples, with defined type of infertility (according to seminogram characteristics, confirmed after two semen analyses), careful control of possible confounding, and elimination of other possible known reasons for male infertility
Yes, these medications can be safely combined as they work through different mechanisms and do not increase hypoglycaemia risk when used together
